Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia

NCT01229566 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Trygg Pharma, Inc.